Search Results - "1752-8062"

PubPharm (1.230)

1

Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker-driven precision dosing

in: Clinical and translational science | (09.01.2021)

by Oni-Orisan, A. | Srinivas, N. | Mehta, K. | +8

2

Contextualising Single-Arm Trials With Real-World Data : An Emulated Target Trial Comparing Therapies For Neovascular Age-Related Macular Degeneration

in: Clinical and translational science | (09.01.2021)

by Thomas, D. | Lee, A. | Müller, P. | +9

3

In Silico Approach to Predict Severe Cutaneous Adverse Reactions Using the Japanese Adverse Drug Event Repot Database

in: Clinical and translational science | (08.01.2021)

by Ambe, K. | Ohya, K. | Takada, W. | +2

4

Compassionate use of Ruxolitinib in patients with SarsCov-2 infection not on mechanical ventilation. Short-term effects on inflammation and ventilation

in: Clinical and translational science | (06.01.2021)

by Mortara, A. | Mazzetti, S. | Margonato, D. | +7

5

Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19. A simulation study

in: Clinical and translational science | (06.01.2021)

by Okada, J. | Yoshinaga, T. | Washio, T. | +3

6

Hybrid physiologically-based pharmacokinetic model for remdesivir : Application to SARS-CoV-2

in: Clinical and translational science | (06.01.2021)

by Gallo, J.

7

Rationale for Effective Prophylaxis Against COVID-19 Through Simultaneous Blockade of Both Endosomal and Non-Endosomal SARS-CoV-2 Entry into Host Cell

in: Clinical and translational science | (06.01.2021)

by Nabavi, S. | Habtemariam, S. | Berindan-Neagoe, I. | +6

8

Adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in cancer patients : A Systematic Review and Meta-Analysis

in: Clinical and translational science | (31.12.2020)

by Yin, X. | Zhao, Z. | Yin, Y. | +7

9

Characterizing the Reproducibility in Using a Liver Microphysiological System for Assaying Drug Toxicity, Metabolism and Accumulation

in: Clinical and translational science | (31.12.2020)

by Rubiano, A. | Indapurkar, A. | Yokosawa, R. | +12

10

Outcomes of concurrent versus sequential icotinib therapy and chemotherapy in advanced non-small-cell lung cancer with sensitive EGFR mutations

in: Clinical and translational science | (31.12.2020)

by Zhang, Y. | Wang, J. | Yu, Z. | +3

1
2
3
4
5
6
7
8
9
10
11
Next »
[123]